Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
28.8M
-
Shares change
-
+513K
-
Total reported value, excl. options
-
$162M
-
Value change
-
+$2.5M
-
Put/Call ratio
-
3.27
-
Number of buys
-
59
-
Number of sells
-
-52
-
Price
-
$5.61
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q1 2022
160 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q1 2022.
ImmunityBio, Inc. - COM (IBRX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (7.16M shares), STATE STREET CORP (6.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.55M shares), JPMORGAN CHASE & CO (1.19M shares), Rafferty Asset Management, LLC (780K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (765K shares), ALLEN HOLDING INC /NY (688K shares), NORTHERN TRUST CORP (667K shares), MILLENNIUM MANAGEMENT LLC (610K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (493K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.